Haider Afzal, MD
Family Medicine · Baytown, TXNPI 1083621023
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,661 of the $7,269 with a category attached, or 64.1%. Photonicare Inc accounts for 64.1% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2024 at $5,018 and has fallen 93.9% since, to $308 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $49.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Photonicare Inc$5K
- Pfizer$353
- AbbVie$325
- AstraZeneca$310
- Boston Scientific$145
- Amgen$143
- plus $1K from 31 others
Across 175 payments — averaging $9411.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lexicon Pharmaceuticals, Inc.$502K
- Ironwood Pharmaceuticals, Inc$315K
- Vertex$289K
- Chiesi USA, Inc.$80K
- Teva Pharmaceuticals USA, Inc.$62K
- AstraZeneca$61K
- plus $337K from 12 others
What the payments were for
- Food & beverage$2,60736%
- Other$4,66164%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Photonicare Inc | 1 | $4,661 |
| Pfizer | 24 | $353 |
| AbbVie(2 entities) | 25 | $325 |
| AstraZeneca | 17 | $310 |
| Boston Scientific | 1 | $145 |
| Amgen(2 entities) | 10 | $143 |
| Lilly USA, LLC | 7 | $136 |
| Bayer | 6 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $120 |
| Supernus Pharmaceuticals, Inc. | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| GSK | 3 | $62 |
| Dexcom, Inc. | 3 | $56 |
| Exact Sciences | 2 | $50 |
| Boehringer Ingelheim | 2 | $48 |
| Insulet Corporation | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Indivior Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Merck | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Mannkind Corporation | 2 | $30 |
| Dermira, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Si-bone, Inc. | 1 | $19 |
| Avvisto Therapeutics, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,269 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 135 | $161,461 |
| JardianceEmpagliflozin | 145 | $160,938 |
| EliquisApixaban | 95 | $80,234 |
| FarxigaDapagliflozin Propanediol | 65 | $62,646 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 71 | $52,273 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $34,706 |
| TivicayDolutegravir Sodium | 15 | $34,042 |
| TradjentaLinagliptin | 35 | $29,188 |
| TrulicityDulaglutide | 19 | $29,167 |
| JanuviaSitagliptin Phosphate | 17 | $20,201 |
| Darunavir | 13 | $17,099 |
| Tresiba Flextouch U-100Insulin Degludec | 31 | $14,569 |
| MounjaroTirzepatide | 15 | $14,435 |
| SymbicortBudesonide/Formoterol Fumarate | 58 | $13,090 |
| LinzessLinaclotide | 14 | $11,388 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Synjardy | $48 | $197,480193 claims |
| Novo NordiskOzempic | $21 | $161,461135 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $310 | $128,008194 claims |
| PfizerEliquis | $353 | $80,23495 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $62 | $50,30385 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $136 | $46,43648 claims |
| MerckJanuvia, Janumet, Janumet Xr | $35 | $38,60249 claims |
| AbbVieLinzess | $325 | $11,38814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Baytown
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.